AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

BridgeBio Pharma, Inc.

$74.95 -$3.29 (-4.21%)
NASDAQ · 30 Oct 2026 20:00 UTC
Previous Close
$70.73
Day Range
$71.91$75.85
Year Range
$60.22$93.42
Market Cap
14.6B
AVG Volume
3.05M
Trailing/Forward PE
-24.65/-
PEG ratio
1.21
Dividend Yield
-
Next Earnings Date
2027-02-23
Primary Exchange
NASDAQUS
Revenue (USD) · TTM
0250M500M750M1B24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
BBIO Revenue (USD) by quarter, trailing twelve months
PeriodRevenue (USD)
26 Q3945.54M
26 Q2713.07M
26 Q1579.96M
25 Q4502.08M
25 Q3353.78M
25 Q2235.81M
25 Q1127.42M
24 Q4221.9M
24 Q3217.76M
24 Q2219.12M
Net Income (USD) · TTM
-800M-600M-400M-200M024 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
BBIO Net Income (USD) by quarter, trailing twelve months
PeriodNet Income (USD)
26 Q3-570.21M
26 Q2-696.24M
26 Q1-725.93M
25 Q4-729.31M
25 Q3-797.12M
25 Q2-776.41M
25 Q1-667.97M
24 Q4-535.76M
24 Q3-438.86M
24 Q2-453.82M
Operating Income (USD) · TTM
-800M-600M-400M-200M024 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
BBIO Operating Income (USD) by quarter, trailing twelve months
PeriodOperating Income (USD)
26 Q3-409.91M
26 Q2-543.47M
26 Q1-570.67M
25 Q4-569.09M
25 Q3-609.88M
25 Q2-656.43M
25 Q1-697.69M
24 Q4-592.97M
24 Q3-544.36M
24 Q2-510.3M
EBITDA · TTM
Cash Flows · TTM
EPS · TTM
Expenses · TTM
Cash & Debt · TTM
Debt ratios · TTM
Margins · TTM
Return on Capital · TTM
Shares Outstanding · TTM
Dividends (USD) · TTM
Employee Count
Book Value Per Share · TTM
Total Assets · TTM
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: BBIO

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 23 Feb 2027.

BridgeBio Pharma, Inc.
BBIO
Stockpicker

Video analysis: BBIO

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: BBIO

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.